ANAPTYSBIO, INC (ANAB) insider trading

By person

22 insiders · 180 transactions

35.0×

Daniel Faga holds 35.0 times base salary in stock. $24.74M of shares against $706.01K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Faga last reported holding, valued at $49.87, the price Common Stock was last bought or sold at on the open market here, on 1 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

EcoR1 Capital, LLC entity

Director

$97.56M (14)

$14.45M (1)

+$83.10M

15,400,518

51.51%

$768.09M

+35.9%

Novo Holdings A/S entity

10% owner

$750.00K (1)

$23.32M (9)

−$22.57M

1,936,604

6.48%

$96.59M

—

Hamza Suria

President, CEO

—

$15.75M (25) scheduled

−$15.75M

68,600

0.2295%

$3.42M

—

Daniel Faga

President, CEO

—

$6.34M (16)

−$6.34M

495,965

1.66%

$24.74M

+12,247%

Frazier Healthcare V, LP entity

10% owner

$6.00M (2)

—

+$6.00M

1,062,321

3.55%

$52.98M

—

Frazier Healthcare VII, L.P.

10% owner

$6.00M (2)

—

+$6.00M

1,284,903

4.30%

$64.08M

—

James N Topper

Director

$6.00M (2)

—

+$6.00M

980,512

3.28%

$48.90M

+736.4%

Eric J Loumeau

Chief Legal Officer

—

$4.40M (26) scheduled

−$4.40M

12,835

0.0429%

$640.14K

+157.0%

Marco Londei

Chief Medical Officer

—

$4.07M (9) scheduled

−$4.07M

68,579

0.2294%

$3.42M

—

Dominic Piscitelli

Chief Financial Officer

—

$2.67M (6) scheduled

−$2.67M

0.0000%

$0.00

—

Nicholas Lydon

Director

$249.99K (1)

$2.87M (7)

−$2.62M

271,106

0.9069%

$13.52M

+302.6%

Dennis Mulroy

Chief Financial Officer

—

$2.31M (13) scheduled

−$2.31M

21,852

0.0731%

$1.09M

+474.3%

Hollings Renton

Director

—

$1.62M (10) scheduled

−$1.62M

10,995

0.0368%

$548.37K

—

John P. Schmid

Director

—

$1.16M (3)

−$1.16M

37,652

0.1259%

$1.88M

—

Avalon Ventures VII L P entity

10% owner

—

$901.92K (1)

−$901.92K

0.0000%

$0.00

−100.0%

Paul F. Lizzul

Chief Medical Officer

—

$895.16K (10)

−$895.16K

42,088

0.1408%

$2.10M

+808.2%

Magda Marquet

Director

—

$530.53K (2) scheduled

−$530.53K

9,930

0.0332%

$495.25K

—

J. Anthony Ware

Director

$50.58K (1)

$193.34K (1)

−$142.76K

9,630

0.0322%

$480.29K

—

Dennis M Fenton

Director

—

$117.45K (2) scheduled

−$117.45K

4,965

0.0166%

$247.63K

—

Carol Giltner Gallagher

Director

—

64,296

0.2151%

$3.21M

—

John A Orwin

Director

—

17,995

0.0602%

$897.49K

—

Rita Jain

Director

—

11,864

0.0397%

$591.71K

—

ANAPTYSBIO, INC

What the insiders did Net buying

By person